7-76625627-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012230.5(POMZP3):c.122C>T(p.Pro41Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012230.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMZP3 | NM_012230.5 | c.122C>T | p.Pro41Leu | missense_variant | 3/7 | ENST00000310842.9 | NP_036362.3 | |
LINC03009 | NR_029411.1 | n.625-294G>A | intron_variant, non_coding_transcript_variant | |||||
POMZP3 | NM_152992.4 | c.122C>T | p.Pro41Leu | missense_variant | 3/5 | NP_694537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POMZP3 | ENST00000310842.9 | c.122C>T | p.Pro41Leu | missense_variant | 3/7 | 1 | NM_012230.5 | ENSP00000309233 | P1 | |
LINC03009 | ENST00000418663.5 | n.606-294G>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152006Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251176Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135740
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461638Hom.: 0 Cov.: 35 AF XY: 0.0000110 AC XY: 8AN XY: 727128
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152006Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74230
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.122C>T (p.P41L) alteration is located in exon 3 (coding exon 2) of the POMZP3 gene. This alteration results from a C to T substitution at nucleotide position 122, causing the proline (P) at amino acid position 41 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at